首页> 外文会议>2011 International Reliability Physics Symposium >Implantable medical electronics: Race to the bottom or race to the future?
【24h】

Implantable medical electronics: Race to the bottom or race to the future?

机译:植入式医疗电子产品:竞标到底还是竞标未来?

获取原文

摘要

Implantable Medical Electronics have made tremendous strides improving the lives of millions of people over the last half century, yet realizing the full promise of this application to treat chronic disease across the globe in both developed and emerging markets has been limited by a number of constraints such as health care access, therapy delivery, total cost of care, system reliability, time and cost to prove clinical evidence, cultural attitudes towards chronic disease, and lack of information and innovation to address prevention of disease rather than just palliative care. New approaches for overcoming these constraints with innovation in ideas and application of technology can make meaningful impacts helping people worldwide live fuller lives with improved health care system outcomes in both cost and quality of care. This innovation is needed to create a better future for patients by engaging medical device makers, health care providers, reimbursement and regulatory bodies in a race to the future - a competitive landscape of innovative technologies that improve patient care, rather than a race to the bottom - a highly constrained, commodity device landscape with lowered incentives that slow innovation in the practice of medicine. Paul has served in his present role as Medtronic Tempe Campus Technology Director, since January 2008. In this role, he is responsible for technology development, design automation and product development for the New Therapies and Diagnostics organization within the Cardiac Rhythm Disease Management business unit of Medtronic. The Tempe campus technology organization includes over 90 personnel with competencies in developing and supporting next generation technologies and design environments for integrated circuits, electronic packaging and implantable sensors, brought together to enable system solutions across multiple business units of Medtronic. They are energized by the belief that there is still tremendous opportunity for hardwar--e solutions to contribute toward making a difference in improving the lives of people worldwide.
机译:在过去的半个世纪中,可植入医疗电子设备取得了长足的进步,改善了数百万人的生活,但是,由于许多限制因素,使这种用于治疗慢性病的药物在发展中国家和新兴市场的全面前景受到了限制。例如医疗保健,治疗的提供,总体护理成本,系统可靠性,证明临床证据所需的时间和成本,对慢性病的文化态度以及缺乏信息和创新来应对疾病的预防,而不仅仅是姑息治疗。通过创新思想和应用技术来克服这些限制的新方法可以产生有意义的影响,从而帮助世界各地的人们过上更充实的生活,同时改善医疗保健系统的医疗成本和质量。通过与医疗器械制造商,医疗保健提供者,报销和监管机构进行竞争以创造对未来的竞争,需要创新才能为患者创造更美好的未来-改善患者护理的创新技术的竞争格局,而不是底线竞赛-高度受限的商品设备格局,激励措施降低,减缓了医学实践的创新。自2008年1月起,Paul一直担任现任Medtronic Tempe校园技术总监。在此职位上,Paul负责心脏节律疾病管理业务部门新疗法和诊断组织的技术开发,设计自动化和产品开发。美敦力。坦佩校园技术组织包括90多名员工,他们具有开发和支持集成电路,电子封装和可植入传感器的下一代技术和设计环境的能力,这些人员汇集在一起​​就可以为美敦力的多个业务部门提供系统解决方案。他们深信,仍然有巨大的机会进行艰苦的战争, -- 有助于改变世界人民生活的解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号